Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 94.90
+1.70 (1.82%)
Apr 29, 2026, 5:24 PM CET
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 61.80M SEK in the quarter ending March 31, 2026, with 12.77% growth. This brings the company's revenue in the last twelve months to 257.50M, up 16.52% year-over-year. In the year 2025, Devyser Diagnostics AB had annual revenue of 250.50M with 15.49% growth.
Revenue (ttm)
257.50M
Revenue Growth
+16.52%
P/S Ratio
6.08
Revenue / Employee
2.22M
Employees
116
Market Cap
1.56B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 28.24B |
| Getinge AB | 34.09B |
| Sectra AB | 3.52B |
| Camurus AB | 2.27B |
| Cereno Scientific AB | 44.27M |
| Surgical Science Sweden AB | 992.34M |
| Carasent AB | 349.05M |
| EQL Pharma AB | 425.75M |